Cargando…
Effects of probucol on atherosclerotic plaque and soluble thrombomodulin in patients with coronary heart disease
This study explored the effects of probucol on atherosclerotic plaques and soluble thrombomodulin in patients with coronary heart disease (CHD). Five hundred and eighty-three patients with CHD who were admitted to Jining First People's Hospital from February 2013 to February 2014. A total of 30...
Autores principales: | Liu, Donghai, Yang, Guoping, Zhao, Xuebin, Yang, Huanzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090215/ https://www.ncbi.nlm.nih.gov/pubmed/30116341 http://dx.doi.org/10.3892/etm.2018.6264 |
Ejemplares similares
-
Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE)
por: Yamashita, Shizuya, et al.
Publicado: (2021) -
Add-On Effect of Probucol in Atherosclerotic, Cholesterol-Fed Rabbits Treated with Atorvastatin
por: Keyamura, Yuka, et al.
Publicado: (2014) -
Integrated Analysis of Two Probucol Trials for the Secondary Prevention of Atherosclerotic Cardiovascular Events: PROSPECTIVE and IMPACT
por: Arai, Hidenori, et al.
Publicado: (2022) -
Circulating thrombomodulin in ischemic heart disease: correlation with the extent and severity of coronary atherosclerosis
por: Rizk, A, et al.
Publicado: (2004) -
Expression of osteopontin in calcified coronary atherosclerotic plaques.
por: Kwon, H. M., et al.
Publicado: (2000)